Effects of the angiotensin-1 receptor blocker valsartan compared with amlodipine on renal hemodynamics.
Epstein
Murray
M
Hollenberg
Norman K
NK
D017311:Amlodipine / Q000627:therapeutic use*; D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D005919:Glomerular Filtration Rate / Q000187:drug effects*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy / Q000503:physiopathology; D008833:Microcirculation / Q000187:drug effects; D044140:Receptor, Angiotensin, Type 1 / Q000627:therapeutic use*; D012079:Renal Circulation / Q000187:drug effects*; D013777:Tetrazoles / Q000627:therapeutic use*; D016896:Treatment Outcome; D014633:Valine / Q000031:analogs & derivatives / Q000627:therapeutic use*; D000068756:Valsartan
D047228:Angiotensin II Type 1 Receptor Blockers; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D044140:Receptor, Angiotensin, Type 1; D013777:Tetrazoles; D017311:Amlodipine; D000068756:Valsartan; D014633:Valine